This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AAPL DLA HLS KBR MDCA

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Apple (AAPL - Get Report) was upgraded at Robert Baird to outperform from neutral. $620 price target. 2014 holds more promise for the company, Robert Baird said.

Delta Apparel (DLA - Get Report) was downgraded to hold at TheStreet Ratings.

Donaldson (DCI) was downgraded at Bank of America/Merrill Lynch to underperform from buy. Valuation call, based on a $42 price target, Bank of America/Merrill said.

Innophos (IPHS) was downgraded at Keybanc to hold from buy. Estimates were also cut, as the company lacks near-term catalysts, Keybanc said.

KBR (KBR - Get Report) was upgraded to buy at TheStreet Ratings.

Marketo (MKTO) was upgraded at Goldman Sachs to buy. $45 price target. Stock has pulled back to an attractive entry point and growth is not likely to slow significantly, Goldman Sachs said.

Old National (ONB) was downgraded at FIG Partners to market perform. $16 price target. Company is facing higher costs, FIG Partners said.

Susquehanna (SUSQ) was upgraded at Sterne Agee to buy. Company is cutting costs, and the earnings bar has been reset to a more reasonable level, Sterne Agee said.

Volcano (VOLC) was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a $23 price target, Credit Suisse said.

Webster (WBS) was downgraded at Sterne Agee to neutral from buy. Valuation call, as the stock moved through the $28 price target, Sterne Agee said.

Stock Comments/EPS Changes

Apple numbers were raised at J.P. Morgan. Shares are now seen reaching $600. Estimates were also increased through 2014 on strong quarterly results. Overweight rating.

Apple numbers were raised at Barclays. Shares are now seen reaching $585. Estimates were also increased on strong quarterly results, Barclays said. Overweight rating.

Healthsouth (HLS - Get Report) price target, estimates were raised at UBS. Healthsouth lifted its estimates across the board. Higher revenue and favorable workers comp reversal drive upside, UBS said. $35.50 price target and neutral rating.

MDC Partners (MDCA - Get Report) estimates, price target were lifted at UBS. The company continues to outgrow the industry and return cash to shareholders, UBS said. $34 price target and buy rating.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $125.85 -2.20%
DLA $12.28 -0.24%
HLS $41.96 -3.20%
MDCA $20.63 2.00%
KBR $17.80 0.23%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs